Among these biomarkers, soluble CD163 (sCD163) levels increase in both CSF and plasma samples, related to the activation of macrophage/microglia and inflammation levels in neurological diseases, supporting its role also as a cognitive impairment biomarker [34,35,36,37]. Here, CD163 is linked to Cognitive impairment.